A detailed history of Geode Capital Management, LLC transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 192,563 shares of MAIA stock, worth $402,456. This represents 0.0% of its overall portfolio holdings.

Number of Shares
192,563
Previous 156,742 22.85%
Holding current value
$402,456
Previous $536,000 0.93%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.54 - $3.87 $90,985 - $138,627
35,821 Added 22.85%
192,563 $541,000
Q2 2024

Aug 09, 2024

BUY
$1.96 - $5.1 $202,830 - $527,773
103,485 Added 194.31%
156,742 $536,000
Q1 2024

May 13, 2024

BUY
$1.1 - $2.55 $9,570 - $22,185
8,700 Added 19.53%
53,257 $117,000
Q3 2023

Nov 13, 2023

BUY
$1.42 - $2.41 $15,009 - $25,473
10,570 Added 31.1%
44,557 $98,000
Q2 2023

Aug 11, 2023

BUY
$2.11 - $3.84 $71,712 - $130,510
33,987 New
33,987 $74,000

Others Institutions Holding MAIA

About MAIA Biotechnology, Inc.


  • Ticker MAIA
  • Exchange
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,935,900
  • Market Cap $22.9M
  • Description
  • MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...
More about MAIA
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.